Support & Funding

Current

NIAAA R21 AA028800 A NOVEL ROLE FOR MIDBRAIN GLUTAMATE CO-TRANSMITTING NEURONS IN ALCOHOL DRINKING AND MOTIVATED BEHAVIORS (Torregrossa/Logan/Freyberg)

NIDA R21 DA052419 ULTRA-FAST HIGH-RESOLUTION IMAGING OF WHOLE MOUSE BRAIN FOR THE STUDY OF DRUG ADDICTION (Freyberg/Watson/Logan)

NIDA R33 DA041872 GENERATING NOVEL MOUSE TOOLS TO INVESTIGATE BRAIN REGION AND CELL-TYPE SPECIFIC CIRCADIAN MOLECULAR MECHANISMS OF REWARD AND MOTIVATION (Logan/McClung)

NHLBI R01 HL150432-S1 SUPPLEMENT – NIA

NHLBI R01 HL150432 CELL-TYPE SPECIFIC ROLE OF CIRCADIAN-DEPENDENT TRANSCRIPTION IN FENTANYL-INDUCED SYNAPTIC AND BEHAVIORAL PLASTICITY (Logan)

NIDA R01 DA051390 MOLECULAR RHYTHM ALTERATIONS IN HUMAN POST-MORTEM BRAIN ASSOCIATED WITH OPIOID USE DISORDER (Seney/Logan)

Past

NIDA R21 DA041872 GENERATING NOVEL MOUSE TOOLS TO INVESTIGATE BRAIN REGION AND CELL-TYPE SPECIFIC CIRCADIAN MOLECULAR MECHANISMS OF REWARD AND MOTIVATION (Logan/McClung) 2017-2019

Regenacy Pharmaceuticals Sponsored Project INVESTIGATING THE THERAPEUTIC POTENTIAL OF HDAC INHIBITORS FOR THE TREATMENT OF BIPOLAR DISORDER (Logan) 2017-2018

Yale-NIDA Neuroproteomics Pilot Grant NOVEL BINDING PARTNERS OF THE CIRCADIAN TRANSCRIPTION FACTOR NPAS2 TO REGULATE COCAINE REWARD (Logan) 2016-2017

Competitive Medical Research Fellowship University of Pittsburgh School of Medicine USING CRISPR/CAS TO DEVELOP NOVEL MOUSE MODELS TO STUDY ADDICTION (Logan) 2016-2017

NIDA K01 DA038654 THE ROLE OF THE CIRCADIAN TRANSCRIPTION FACTOR NPAS2 IN THE NUCLEUS ACCUMBENS TO REGULATE COCAINE REWARD (Logan) 2015-2019

NARSAD Young Investigator Award IDENTIFYING NEUROTHERAPEUTIC EPIGENETIC TARGETS FOR THE TREATMENT OF BIPOLAR DISORDER (Logan) 2014-2016